Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of immunology"
DOI: 10.1093/jimmun/vkaf263
Abstract: Abstract The National Institutes of Health–funded IMPACC (IMmunoPhenotyping Assessment in a COVID-19 Cohort) evaluated longitudinal clinical and immunological features of human patients hospitalized for COVID-19. This study focuses on comparing the novel NULISAseq assay with… read more here.
Keywords: evaluating covid; severity; severity prediction; covid severity ... See more keywords
The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)
Sign Up to like & getrecommendations! Published in 2024 at "BMC Public Health"
DOI: 10.1186/s12889-024-18576-w
Abstract: When formulating and evaluating COVID-19 vaccination strategies, an emphasis has been placed on preventing severe disease that overburdens healthcare systems and leads to mortality. However, more conventional outcomes such as quality-adjusted life years (QALYs) and… read more here.
Keywords: disease; evaluating covid; vaccination; impact ... See more keywords